Polomar Health Services Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Polomar Health Services Inc (PMHS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Polomar Health Services Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 3M vs -M combined for tracked competitors (100.0% combined share).
- Trending: Latest-quarter revenue run-rate is accelerating (+92.7% annualized vs trailing 12 months).
- Peer revenue share: Polomar Health Services Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
PMHS Sales vs. its Competitors, Q2 2026
Polomar Health Services Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.
For context: the Major Pharmaceutical Preparations industry grew revenue 9.0% year over year, combined, vs 27,694.6% for Polomar Health Services Inc. Polomar Health Services Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
PMHS Stock Performance relative to its Competitors
Polomar Health Services Inc's Comment on Competition and Industry Peers
Polomar Health Services Inc's Competitors Named by the Company
Competitive relationships identified from SEC filings and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| ZipHealth, Inc. | Named by the company | 85% |
| Hims/Hers | Named by the company | 85% |
| Levity Healthcare, Inc. | Named by the company | 85% |
Filing basis, confidence, active dates and source counts for Polomar Health Services Inc's named competitors require a Commercial License.
Methodology: relationships are extracted from SEC filings (named-competitor disclosures) and corroborating sources. Named by the company = explicitly disclosed as a competitor; Inferred = derived from corroborating signals. Confidence reflects evidence strength.
